Ramanjaneyulu Allam
7PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 31, 2024
Ribonuclease inhibitor and angiogenin system regulates cell type-specific global translation.Martina Stillinovic, Mayuresh Anant Sarangdhar, Nicola Andina
|Apr 21, 2023
Human molecular genetics sheds light on the physiological significance of ribonuclease inhibitor (RNH1).Mayuresh Anant Sarangdhar, Nicola Andina, Ramanjaneyulu Allam
|Jan 20, 2023
Increased Inflammasome Activation Is Associated with Aging and Chronic Myelomonocytic Leukemia Disease Severity.Nicola Andina, Louise de Meuron, Annatina Sarah Schnegg-Kaufmann
|Mar 08, 2022
LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity.Giuseppe Bombaci, Mayuresh Anant Sarangdhar, Nicola Andina
|Nov 27, 2021
Diagnostic and Prognostic Implications of Caspase-1 and PD-L1 Co-Expression Patterns in Myelodysplastic Syndromes.Johannes R Graf, Stefan Forster, Frido K Bruehl
|Jul 02, 2021
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine.Ioannis Chanias, Kristina Stojkov, Gregor Th Stehle
Pageof 2
Frequent Collaborators
4 joint publications
Mayuresh Anant Sarangdhar
3 joint publications
Giuseppe Bombaci
2 joint publications
Naomi A Porret
2 joint publications
Vera Ulrike Bacher
2 joint publications
Nicolas Bonadies
2 joint publications
Nicola Andina
1 joint publications
Tata Nageswara Rao
1 joint publications
Rudolf Benz
1 joint publications
Adrian Schmidt
1 joint publications
Anne Angelillo-Scherrer
